Skip to main content

Jun Chen

Professor of Medicine
Medicine, Hematologic Malignancies and Cellular Therapy
Box 103866 Med Ctr, Durham, NC 27710
GSRB1 Rm 4004B, 905 S LaSalle Street, Durham, NC 27710

Featured Works


Prophylaxis and treatment of acute graft-versus-host disease.

Journal article Semin Hematol · January 2006 Featured Publication Acute graft-versus-host disease (GVHD) remains a major obstacle to successful allogeneic hematopoietic stem cell transplantation (HSCT). The ability to prevent GVHD--the application of successful prophylaxis--is crucial as treatment when prophylaxis fails ... Full text Link to item Cite

The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation.

Journal article Am J Respir Crit Care Med · April 15, 2005 Featured Publication Rapid and selective recruitment of neutrophils into the airspace in response to LPS facilitates the clearance of bacterial pathogens. However, neutrophil infiltration can also participate in the development and progression of environmental airway disease. ... Full text Link to item Cite

Selective elimination of alloreactivity from immunotherapeutic T cells by photodynamic cell purging and memory T-cell sorting.

Journal article Cytotherapy · 2005 Featured Publication Allogeneic stem cell transplantation (alloSCT), especially in the mismatched setting, carries a high risk of life-threatening GvHD because of activation of donor T cells by Ag present on host cells. Removal of mature donor T cells can prevent GvHD but lead ... Full text Link to item Cite

Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation.

Journal article Blood · June 1, 2004 Featured Publication In the current study, we tested whether higher numbers of hematopoietic stem cells correlate with the speed of immune reconstitution in a congenic transplantation model (C57BL/Ka, CD45.1, Thy1.1-->C57BL/6, CD45.2, Thy1.2) using purified hematopoietic stem ... Full text Link to item Cite

Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.

Journal article Blood · February 15, 2004 Featured Publication The major challenge in allogeneic hematopoietic cell transplantation is how to transfer allogeneic T-cell immunity without causing graft-versus-host disease (GVHD). Here we report a novel strategy to selectively prevent GVHD by depleting CD62L(+) T cells ( ... Full text Link to item Cite

Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice.

Journal article Exp Hematol · October 2003 Featured Publication OBJECTIVE: To test in a murine model whether recombinant human growth hormone can promote immune recovery after allogeneic T-cell-depleted bone marrow transplantation. MATERIALS AND METHODS: Lethally irradiated (8.5 Gy) BALB/c mice (H2(d)) were transplante ... Full text Link to item Cite

Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process.

Journal article Blood · May 1, 2002 Featured Publication In this study, we investigated the possibility of selective depletion of donor alloantigen-specific T cells from C57BL/6 (H-2(b)) mice to prevent graft-versus-host disease (GVHD). These cells were first activated with irradiated BALB/c (H-2(d)) host spleen ... Full text Link to item Cite

Addition of a second, different allogeneic graft accelerates white cell and platelet engraftment after T-cell-depleted bone marrow transplantation.

Journal article Blood · March 15, 2002 Featured Publication Significant delays in engraftment and lymphoid recovery are the 2 major challenges in cord blood transplantation. The cause for this delay is presumed to be the low numbers of hematopoietic precursors found in one unit of cord blood. One approach to increa ... Full text Link to item Cite

Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model.

Journal article Transplantation · January 15, 2002 Featured Publication BACKGROUND: PG490-88, a semisynthetic derivative of a novel compound PG490 (triptolide) purified from a Chinese herb (Tripterygium wilfordii Hook F), is effective in prevention of murine graft-versus-host disease (GVHD). METHODS: PG490-88 was administrated ... Full text Link to item Cite

Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells.

Journal article Biol Blood Marrow Transplant · 2002 Featured Publication T-cell recovery following myeloablative preparatory regimens and cord blood transplantation in adult patients gen erally occurs between 1 and 3 years following allogeneic bone marrow transplantation. T-cell reconstitution may involve thymic education of do ... Full text Link to item Cite

A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution.

Journal article Blood · January 1, 2002 Featured Publication Umbilical cord blood has been increasingly used as a source of hematopoietic stem cells. A major area of concern for the use of cord blood transplantation is the delay in myeloid and lymphoid recovery. To directly compare myeloid and lymphoid recovery usin ... Full text Link to item Cite

Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F.

Journal article Leuk Lymphoma · July 2001 Featured Publication Triptolide is a diterpenoid triepoxide purified from a Chinese herb Tripterygium Wilfordii Hook F (TWHF). TWHF has been used in traditional Chinese medicine for more than two thousand years. However, its potential value was recognized by the western medici ... Full text Link to item Cite

T-Cell recovery in adults and children following umbilical cord blood transplantation.

Journal article Biol Blood Marrow Transplant · 2001 Featured Publication T-cell reconstitution following allogeneic stem cell transplantation may involve thymic education of donor-derived precursors or peripheral expansion of mature T cells transferred in the graft. T cell-receptor excision circles (sjTRECs) are generated withi ... Full text Link to item Cite

Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion.

Journal article Transplantation · November 27, 2000 Featured Publication BACKGROUND: PG490-88 is a water soluble, semisynthetic derivative of a novel compound PG490 (triptolide) purified from the Chinese herb Tripterygium Wilfordii Hook F. METHODS: PG490-88 was administrated into recipient mice in a model (B10.D2-->BALB/c) of l ... Full text Link to item Cite

Graft-versus-host disease prevention by rapamycin: cellular mechanisms.

Journal article Biol Blood Marrow Transplant · 2000 Featured Publication Understanding the cellular mechanisms that lead to graft-versus-host disease (GVHD) may lead to alternative approaches in the prevention or therapy of this disease process. In this manuscript, we investigated the mechanisms of action of the immunosuppressi ... Full text Link to item Cite

A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivo.

Journal article Proc Natl Acad Sci U S A · May 14, 1996 Featured Publication Graft-versus-host disease (GVHD) is a T-cell-mediated disease of transplanted donor T cells recognizing host alloantigens. Data presented in this report show, to our knowledge, for the first time that a synthetic copolymer of the amino acids L-Glu, L-Lys, ... Full text Link to item Cite